» Articles » PMID: 29055035

THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2017 Oct 22
PMID 29055035
Citations 256
Authors
Affiliations
Soon will be listed here.
Abstract

The Concise Guide to PHARMACOLOGY 2017/18 provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/10.1111/bph.13883/full. Transporters are one of the eight major pharmacological targets into which the Guide is divided, with the others being: G protein-coupled receptors, ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors and enzymes. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2017, and supersedes data presented in the 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature Committee of the Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

Citing Articles

Defining the Polycystin Pharmacophore Through HTS & Computational Biophysics.

Guadarrama E, Vanoye C, DeCaen P bioRxiv. 2025; .

PMID: 39868095 PMC: 11761769. DOI: 10.1101/2025.01.13.632808.


Glycine and clozapine: potential relevance for the treatment of Parkinson's disease.

Maddaford S, Huot P Neurodegener Dis Manag. 2024; 14(3-4):47-49.

PMID: 38602420 PMC: 11457666. DOI: 10.2217/nmt-2024-0005.


Increased intrinsic membrane excitability is associated with hypertrophic olivary degeneration in spinocerebellar ataxia type 1.

Morrison L, Huang H, Handler H, Fu M, Bushart D, Pappas S bioRxiv. 2023; .

PMID: 37961407 PMC: 10634770. DOI: 10.1101/2023.10.23.563657.


DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features.

Wang Y, Aldahdooh J, Hu Y, Yang H, Vaha-Koskela M, Tang J Sci Rep. 2022; 12(1):21116.

PMID: 36477604 PMC: 9729186. DOI: 10.1038/s41598-022-24980-2.


Influence of tapentadol and oxycodone on the spinal cord and brain using electrophysiology: a randomized, placebo-controlled trial.

Nedergaard R, Hansen T, Morch C, Niesters M, Dahan A, Drewes A Br J Clin Pharmacol. 2022; 88(12):5307-5316.

PMID: 35776835 PMC: 9796052. DOI: 10.1111/bcp.15453.


References
1.
Pinilla-Tenas J, Barber A, Lostao M . Transport of proline and hydroxyproline by the neutral amino-acid exchanger ASCT1. J Membr Biol. 2003; 195(1):27-32. DOI: 10.1007/s00232-003-2041-9. View

2.
Luckner P, Brandsch M . Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1. Eur J Pharm Biopharm. 2004; 59(1):17-24. DOI: 10.1016/j.ejpb.2004.07.008. View

3.
Alexander S, Kelly E, Marrion N, Peters J, Faccenda E, Harding S . THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters. Br J Pharmacol. 2017; 174 Suppl 1:S360-S446. PMC: 5650669. DOI: 10.1111/bph.13883. View